glp-1 weight loss research Agonists Drugs Market Report, 2025-2030 Obesity Clinical Trials | Expert
Description
Midlife has a way of sneaking up on you
Mounjaro offers stronger results with weekly injections vs Saxendas daily doses
As GLP-1 drugs like Ozempic and Mounjaro surge in popularity, new research reveals they cause more muscle loss than fat loss, which is a key concern for those who take them
Januvia is an approved medicine for type 2 diabetes
Results CNR1 expression was upregulated in circulating CD4+ T cells from individuals at type 1 diabetes onset (6.9-fold higher vs healthy individuals) and in sorted islet beta cells from donors with type 1 diabetes (3.6-fold higher vs healthy counterparts)
